Pancreatic Cancer Heavy Ion Treatment Fully Launched with Zero Out-of-Pocket Cost Clinical Research
Pancreatic Cancer Heavy Ion Treatment Fully Launched with Zero Out-of-Pocket Cost Clinical Research Treatment
Inclusion Criteria
- Age 18-70 years, pathologically confirmed pancreatic cancer;
- Meets the criteria for locally advanced pancreatic cancer, without distant metastasis, maximum tumor diameter ≤6cm;
- No prior history of surgery, particle implantation, or other local treatments;
- Good general condition, no organ dysfunction, able to tolerate this treatment;
- Voluntary participation in the study, able to cooperate in completing treatment and follow-up. The above conditions are the main screening criteria; final enrollment is determined by the investigator according to the trial protocol.
Patient Benefits
- The hospital provides research funding to the expert team to cover the patient's heavy ion treatment costs.
- Personalized treatment plans formulated by a pancreatic cancer multidisciplinary expert team (MDT).
- Close follow-up after treatment, providing you with subsequent treatment plans.
Contact Information
Wuwei Heavy Ion Center, Gansu Wuwei Cancer Hospital
Director Chen Weizuo: +86 13519351968
【Precise Escort, Warm Companionship】
Domestic and international expert ward rounds, customizing the optimal plan for your anti-cancer journey!
Every meticulous inquiry is a solemn commitment to life; every rigorous discussion strives for excellence in efficacy.

Professor Fan Ruitai of the First Affiliated Hospital of Zhengzhou University, Henan Province

Professor George Kovacs
Director, Lübeck Brachytherapy Center, Germany
Director of Educational Programs, Università del Sacro Cuore, Italy

Professor Hauffe
Director, Munich Proton Therapy Center, Germany

Professor Hirohiko Tsujii
Pioneer of Heavy Ion Therapy Worldwide
Chairman, International Particle Therapy Cooperative Group (PTCOG)

Professor Shiro Saito
Ohfunato Central Hospital, Japan

Professor Yu Zhilong
Affiliated Hospital of Inner Mongolia Medical University
In the prolonged battle against tumors, precise radiotherapy planning and timely treatment adjustments are crucial. To ensure every patient receiving treatment in the Sixth Department of Radiotherapy at Gansu Wuwei Cancer Hospital benefits from the most advanced, individualized, safe, and effective radiotherapy plans, we consistently uphold and continuously refine a regular ward round system led by domestic and international expert teams.
This is not a routine inspection—it is our "Anti-Cancer Think Tank" in action, safeguarding your treatment!
What Core Benefits Do Expert Ward Rounds Bring You?
- Dynamic Plan Optimization: Based on your real-time treatment response, side effects, and reexamination results, the expert team continuously evaluates efficacy and makes immediate adjustments to radiotherapy plans or doses when necessary, ensuring treatment remains on the optimal path.
- Precision Side Effect Management: We closely monitor potential side effects like gastrointestinal discomfort and fatigue, enabling early detection, intervention, and management to minimize your discomfort and protect your quality of life.
- Personalized Care Guidance: We answer every question you and your family may have during treatment, offering tailored advice on diet, exercise, rehabilitation, and psychological adjustment—so your cancer-fighting journey is never directionless.
- Multidisciplinary Coordination: For patients requiring combined therapies (e.g., chemotherapy, targeted therapy, immunotherapy, surgery), the ward round team efficiently coordinates resources to ensure seamless integration and smooth progression of your treatment plan.
- Dual Control of Quality & Safety: We ensure every step of your treatment is precise and error-free, safeguarding your safety throughout.
Radiotherapy is a dynamic process—no single plan fits all. By persistently inviting domestic and international experts to conduct regular teaching ward rounds, we harness collective expertise to monitor even the subtlest changes in every patient like family, embedding "precision radiotherapy" and "humanistic care" into every day and every phase of treatment. This is our unwavering commitment to you.
Choosing the Radiotherapy Department at Gansu Wuwei Cancer Hospital means selecting not just advanced equipment, but also:
A patient-centered individualized treatment team
An expert think tank by your side
A relentless pursuit of treatment excellence
A warm, supportive partner in your anti-cancer journey
We deeply understand that trust stems from professionalism and responsibility. Let our expert team safeguard your light of life with daily dedication and expertise—guiding you precisely and accompanying you with warmth!
Introduction to the Sixth Department of Radiotherapy
Pancreatic Cancer Heavy Ion Specialty | Abdominopelvic Tumor Heavy Ion Therapy
● Department Overview
The Sixth Department of Radiotherapy specializes in heavy ion therapy for pancreatic cancer and abdominopelvic tumors (liver cancer, colorectal cancer, prostate cancer, etc.). Since its establishment, pancreatic cancer patients nationwide have sought treatment here. We enable precise eradication of pancreatic cancer cells without pain, surgery, or trauma. Having treated dozens of pancreatic cancer patients from across China, we achieve:
≥90% 1-year local control rate
Median survival time extended from 11 months (conventional) to 19 months
Our efficacy is proven, patient experience is exceptional, and results are widely recognized by renowned domestic/international experts and patients.
● Professional Team
Team members graduated from prestigious Chinese medical universities, possessing solid theoretical foundations and rich clinical experience. The department retains experts including Professor Hauffe (Germany), Professor Hirohiko Tsujii (Japan), Professor Ren Yimin (Taiwan), and Professor Wu Jiaming (Taiwan) for complex case consultations, academic lectures, and ward rounds. Our staff trained at leading domestic heavy ion/photon therapy centers, delivering expert-heavy ion treatment planning.

● Treatment Scope
Specializing in heavy ion therapy for pancreatic cancer, we also provide heavy ion/photon therapy for abdominopelvic tumors (liver cancer, colorectal cancer, prostate cancer). We offer professional radiotherapy and personalized comprehensive cancer treatment.
Introduction to Department Experts

Chen Weizuo
Associate Chief Physician
Director, Sixth Department of Radiotherapy
Heavy Ion Center, Gansu Wuwei Cancer Hospital
- "Luyuan Youth Talent" of Gansu Province
- Council Member, Chinese Nuclear Society Branch of Brachytherapy & Smart Radiotherapy
- Committee Member, Ion Radiotherapy Branch, China Association of Medical Equipment
- Committee Member, Oncology Branch, National Association of Health Industry & Enterprise Management
- Youth Committee Member, Western Radiotherapy Association
- Youth Committee Member, CRTOG Radiation Immunotherapy IR Committee
- Youth Committee Member, Gansu Anti-Cancer Association Gastric/Colorectal Cancer Committee
- Committee Member, Wuwei Medical Association Radiotherapy Branch
Research Leadership:
- Principal Investigator, Chinese Academy of Sciences "Western Light" Talent Training Program (1 project)
- Principal Investigator, Gansu Provincial Organization Department "Luyuan Youth Innovation & Entrepreneurship" Talent Program (2 projects)
Awards:
- Third Prize, Gansu Provincial Science & Technology Progress Award
- Gold Medal, National Invention Exhibition
- Second Prize, National "Invention Entrepreneurship Award"
Publications & Patents:
- 11 SCI papers
- 5 core Chinese journal papers
- 2 National Invention Patents
- 3 Utility Model Patents